Stage FocusSeed, Series A, Series B+
GeographyUK, Europe
TypeVC
Last Activity2026
Industry Focus
Industries
BiotechMedtech
Technical BenchStrong
Investor TypeDeepTech Specialist
ExposureMostly DeepTech Investments
Bio
LifeArc Ventures is part of LifeArc, a medical research charity with a remarkable funding model — it's self-financing through royalties from Keytruda (sold to CPPIB for $1.297B in 2019), giving it a substantial permanent capital base. The strategy is to invest £1.3B by 2030, and the portfolio has expanded from 14 companies in 2022 to 20 by end-2025, investing across therapeutics, HealthTech, and m...
Notable Investments
M
Maxion TherapeuticsT
Tribune TherapeuticsR
RQ BiotechnologyC
Closed Loop MedicineSimilar Funds
Syncona
London, United Kingdom
DeepTech NativeBiotechMedtechPre-SeedSeed
Abingworth
London, United Kingdom
DeepTech NativeBiotechMedtechSeedSeries A
AL
Advent Life Sciences
London, United Kingdom
Pure DeepTechBiotechMedtechSeedSeries A
Ahren Innovation Capital
London, United Kingdom
DeepTech NativeBiotechRoboticsClimate TechSeedSeries A
AE
Aquarius Equity
United Kingdom
DeepTech NativeBiotechMedtechSeedSeries A
Brandon Capital
Melbourne, Australia
DeepTech NativeBiotechMedtechSeedSeries A